UPDATE: Abbott Posts Upbeat Q2 Profit
Abbott Laboratories (NYSE: ABT) reported a drop in its second-quarter profit.
Abbott's quarterly profit fell to $476 million, or $0.30 per share, versus $1.73 billion, or $1.08 per share, in the year-earlier quarter. Its adjusted earnings from continuing operations surged to $0.46 per share from $0.43 per share.
Its net sales jumped 2.5% to $5.45 billion from $5.31 billion. However, analysts were projecting earnings of $0.44 per share on sales of $5.52 billion.
Abbott shares closed at $35.70 yesterday.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.